共 14 条
[1]
ALBERTI W, 1995, BRIT MED J, V311, P899
[3]
Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer - A meta-analysis
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2004, 292 (04)
:470-484
[7]
KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO
[8]
2-L
[9]
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer - A randomized trial
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2003, 290 (16)
:2149-2158